Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment

F.Y. De Vos, Willem Lesterhuis, R.J. Brüggemann, W.T. Van Der Graaf

Research output: Contribution to journal › Review article

Access to Document

@article{e8c117e707f7496099d846d382ddfaf7,

title = "Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment",

author = "{De Vos}, F.Y. and Willem Lesterhuis and R.J. Br{\"u}ggemann and {Van Der Graaf}, W.T.",

year = "2012",

doi = "10.1097/CAD.0b013e32834be51a",

language = "English",

volume = "23",

pages = "139--140",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams & Wilkins",

number = "1",

}

TY - JOUR

T1 - Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment

AU - De Vos, F.Y.

AU - Lesterhuis, Willem

AU - Brüggemann, R.J.

AU - Van Der Graaf, W.T.

PY - 2012

Y1 - 2012

U2 - 10.1097/CAD.0b013e32834be51a

DO - 10.1097/CAD.0b013e32834be51a

M3 - Review article

C2 - 21934601

SN - 0959-4973

VL - 23

SP - 139

EP - 140

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

IS - 1

ER -